In contrast to these data, a large single‐centre analysis of stage III epithelioid tumours found that T3 tumours had a greater percentage of strong MSLN immunostaining compared to T2 tumours (51 versus 25%), suggesting that invasiveness was associated with increased MSLN expression.11 The gene discussed is MSLN; the disease is neoplasm.